Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

The smoke alarm has woken you up. You stumble to the top of the stairs and see the reflection of flames in the glass of a picture frame. Your nightmare has come true: Your house is on fire, and ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Nairobi, Kenya: Merck, a leading company for innovative ... Campaign in partnership with Kenya Ministry of Health and Diabetes Management and Information centre (DMI) on the occasion of the ...

falling short of the Medical sector's loss of 4.16% and the S&P 500's gain of 2.76%. The investment community will be closely monitoring the performance of Merck in its forthcoming earnings report.

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, is a pharmaceutical company that develops and markets prescription medicines, vaccines, biologic therapies and animal health products.